US81727U1051

Health

Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems

Eversense 365 delivered favorable glucometrics compared to other open and closed loop systems, validating the one-year CGM’s differentiated approach and…

3 weeks ago

Health

Senseonics Announces Pricing of $80 Million Public Offering of Common Stock and Pre-Funded Warrants

April 30, 2026 21:50 ET | Source: Senseonics Holdings, Inc. GERMANTOWN, Md., April 30, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings,…

2 months ago

Health

First Ever Real-World Evidence of Eversense 365 Presented at ATTD Demonstrates Sustained Performance and Positive Impact Throughout One-Year of Wear

March 14, 2026 10:15 ET | Source: Senseonics Holdings, Inc. New data shows positive real-world impact of the world’s first…

3 months ago

Health

Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365

September 03, 2025 17:17 ET | Source: Senseonics Holdings, Inc. CGM commercial operations to transition from Ascensia Diabetes Care to…

10 months ago

Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems

Senseonics Announces Pricing of $80 Million Public Offering of Common Stock and Pre-Funded Warrants

First Ever Real-World Evidence of Eversense 365 Presented at ATTD Demonstrates Sustained Performance and Positive Impact Throughout One-Year of Wear

Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365

Headline